期刊文献+

CKD3~5期维持性血液透析患者腹主动脉钙化的发生及其进展相关因素 被引量:3

Occurrence of abdominal aortic calcification and related factors of its progress in CKD patients at stage 3-5 undergoing maintenance hemodialysis
下载PDF
导出
摘要 目的:探讨慢性肾脏病(chronic kidney disease,CKD)3~5期维持性血液透析患者腹主动脉钙化(abdominal aortic calcification,AAC)发生及进展情况,分析其影响因素。方法:选取2017年1月至2018年3月阜阳市第二人民医院80例CKD3~5期维持性血液透析患者,分析影响患者AAC发生及进展的危险因素。结果:80例CKD3~5期维持性血液透析患者中包括无钙化者44例,钙化者36例;Logistic回归分析结果显示,年龄、高血压病史、糖尿病病史、冠心病史、C反应蛋白、血磷、三酰甘油、全段甲状旁腺激素是CKD3~5期维持性血液透析患者AAC发生的独立危险因素,25羟维生素D是影响AAC的保护因素;随访2年,共有67例患者复查腹部侧位X线片完成随访,其中AAC进展组32例(新发14例),非AAC进展组35例;Logistic回归分析结果显示,年龄、血磷、C反应蛋白、三酰甘油、全段甲状旁腺激素是CKD3~5期维持性血液透析患者AAC进展的独立危险因素,25羟维生素D、高密度脂蛋白是影响AAC进展的保护因素。结论:年龄、高血磷、高血压病史、糖尿病病史、冠心病史、高水平C反应蛋白、低水平25羟维生素D、高三酰甘油、高全段甲状旁腺激素是血液透析患者AAC发生的独立危险因素,高水平血磷及低水平25羟维生素D、高三酰甘油、高全段甲状旁腺激素、高密度脂蛋白胆固醇是血液透析患者AAC进展的独立危险因素。 Objective:To explore the occurrence and progress of abdominal aortic calcification(AAC)in patients with chronic kidney disease(CKD)at stage 3-5 undergoing maintenance hemodialysis,and analyze its influencing factors.Methods:A total of 80 CKD patients at stage 3-5 who underwent maintenance hemodialysis in Fuyang Second People’s Hospital from January 2017 to March 2018 were enrolled.The risk factors that affected the occurrence and progress of AAC were analyzed.Results:Among the 80 CKD patients at stage 3-5 undergoing maintenance hemodialysis,there were 44 cases without calcification and 36 cases with calcification.The results of Logistic regression analysis showed that age,histories of hypertension,diabetes,coronary heart disease,C-reactive protein,serum phosphorus,triacylglycerol and intact parathyroid hormone were independent risk factors of AAC occurrence,while 25-hydroxyvitamin D was a protective factor.They were followed up for 2 years and 67 patients were followed up with X-rays reexamination at the abdominal lateral side,including 32 cases(14 new onset cases)in AAC progress group and 35 cases in non-AAC progress group.The results of Logistic regression analysis showed that age,serum phosphorus,C-reactive protein,triacylglycerol and intact parathyroid hormone were independent risk factors of AAC progress,while 25-hydroxyvitamin D and high-density lipoprotein were protective factors.Conclusion:Age,serum phosphorus,histories of hypertension,diabetes,coronary heart disease,high level of C-reactive protein,low levels of 25-hydroxyvitamin D,triacylglycerol and intact parathyroid hormone affect the occurrence of AAC in hemodialysis patients,independently while high-level serum phosphorus,low-level 25-hydroxyvitamin D,high-level triacylglycerol,high-level intact parathyroid hormone and low-level high-density lipoprotein cholesterol affect the progress of AAC independently.
作者 马涛 李秀勇 MA Tao;LI Xiuyong(Blood Purification Center,Fuyang Second People’s Hospital,Fuyang Anhui 236000,China)
出处 《临床与病理杂志》 CAS 2021年第4期770-776,共7页 Journal of Clinical and Pathological Research
关键词 维持性血液透析 腹主动脉钙化 进展 危险因素分析 maintenance hemodialysis abdominal aortic calcification progress risk factor analysis
  • 相关文献

参考文献7

二级参考文献37

  • 1Levey AS, Coresh J. Chronic kidney disease[ J]. Lancet,2012,379: 165 - 180.
  • 2Levey AS,de Jong PE, Coresh J, et al. The definition,classification, and prognosis of chronic kidney disease:a KDIGO Controversies Conference report [ J ]. Kidney Int, 2011,80 : 17 - 28.
  • 3Dorresteijn JA,van der Graaf Y, Spiering W, et al. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease : J-curve revisited [ J ]. Hypertension, 2012, 59(1) :14 -21.
  • 4Zhang J, Xie X, Li C, Fu P. Systematic review of the renal protective effect of Astragalusmembranaceus (root) on diabetic nephropathy in animal models [ J ]. JEthnopharmaco1,2009,126 ( 2 ) : 189 - 196.
  • 5KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease [ J ]. Kidney inter, 2012,2 (Sup- pl) :279 - 335.
  • 6Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction : incidence and clinical significance [ J ]. Chest,2004,125 : 1877 - 1884.
  • 7Iliou MC, Fumeron C, Benoit MO, et al. Factors associated with in- creased serum levels of cardiac troponins T and I in chronic haemo- dialysis patients:Chronic HaemodialysisAnd New Cardiac Markers Evaluation (CHANCE) study [ J ]. Nephrol Dial Transplant, 2001, 16 : 1452 - 1458.
  • 8Mallamaci F, Zoccali C, Padongo S, et al. Troponin is related to left ventrieular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients[J]. Am J Kidney Dis,2002,40:68 - 75.
  • 9Ix JH, Criqui MH. Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease [ J ]. Adv Chronic Kidney Dis ,2008,15:378 - 383.
  • 10Saini T, Murtagh FE, Dupont PJ, et al. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease [ J ]. Palliat Med,2006 ,20 :631 - 636.

共引文献280

同被引文献35

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部